1. Home
  2. Labeler Index
  3. Patheon, Inc.
  4. 63285-865
  5. NDC Package Code: 63285-865-00 Dasatinib

NDC Package 63285-865-00 Dasatinib

Tablet - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
63285-865-00
Package Description:
30194 TABLET in 1 DRUM
Product Code:
63285-865
Non-Proprietary Name:
Dasatinib
Substance Name:
Dasatinib
Usage Information:
This medication is used to treat certain types of cancer (chronic myeloid leukemia-CML, acute lymphoblastic leukemia-ALL). It works by slowing or stopping the growth of cancer cells.
11-Digit NDC Billing Format:
63285086500
Product Type:
Drug For Further Processing
Labeler Name:
Patheon, Inc.
Dosage Form:
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Active Ingredient(s):
  • DASATINIB 80 mg/1
    • Sample Package:
    N/A
    Marketing Category:
    DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
    Start Marketing Date:
    10-28-2010
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Unfinished Product:
    Yes
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 63285-865-00?

    The NDC Packaged Code 63285-865-00 is assigned to an UNFINISHED drug package of 30194 tablet in 1 drum of Dasatinib, drug for further processing labeled by Patheon, Inc.. The product's dosage form is tablet and is administered via form.

    Is NDC 63285-865 included in the NDC Directory?

    Yes, Dasatinib is an UNFINISHED PRODUCT with code 63285-865 that is active and included in the NDC Directory. The product was first marketed by Patheon, Inc. on October 28, 2010 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 63285-865-00?

    The 11-digit format is 63285086500. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-263285-865-005-4-263285-0865-00